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Split inteins are powerful tools for seamless ligation of synthetic split proteins. Yet, their use
remains limited because the already intricate split site identification problem is often com-
plicated by the requirement of extein junction sequences. To address this, we augment a
mini-Mu transposon-based screening approach and devise the intein-assisted bisection
mapping (IBM) method. IBM robustly reveals clusters of split sites on five proteins, con-
verting them into AND or NAND logic gates. We further show that the use of inteins expands
functional sequence space for splitting a protein. We also demonstrate the utility of our
approach over rational inference of split sites from secondary structure alignment of
homologous proteins, and that basal activities of highly active proteins can be mitigated by
splitting them. Our work offers a generalizable and systematic route towards creating split
protein-intein fusions for synthetic biology.
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Inteins are internal protein elements that are expressed as partof a larger precursor protein1–3. Upon proper folding, anintein excises itself from the precursor protein and ligates the
flanking external proteins (exteins) with a peptide bond. This
process is known as protein splicing and it produces a product as
if the intein was absent from the original gene sequence. Given
this unique property, inteins are a popular choice for near-
seamless protein ligations, and they become popular with syn-
thetic biologists and biochemists who seek to engineer and che-
mically modify proteins of their choice.
Inteins can be further classified into contiguous or split inteins.
For the latter, the intein is expressed as two separate peptides that
can spontaneously self-assemble and perform protein splicing.
Split inteins thus enable reconstitution of separate coding
sequences with minimal scarring, reducing the chance of hav-
ing additionally inserted domains that might compromise the
original protein function upon structural reconstitution. For pro-
tein chemists, the introduction of split inteins enabled new protein
modification techniques including protein semi-synthesis4,5,
labeling6,7, and circularization8,9. For synthetic biologists, split
inteins are ideal tools for implementing digital logic. A protein can
be divided into two and be fused with a split intein, such that the
bipartite fragments remain individually inactive10, and protein
function is not restored until protein splicing occurs. This effec-
tively generates an AND or NAND logic to integrate two biological
signals. This strategy has been employed in generating in vivo
DNA sensors11, protein-based logic gates for bio-computation12,13
and enforcing dual conditions in directed evolution14. It can be
further used to reduce protein sizes for viral delivery15 and to free
up selection pressures in plasmid maintenances16–18. Many con-
tiguous and split inteins were discovered and studied, and our
group recently characterized a library of orthogonal split inteins
extensively3. Yet, despite the availability of inteins and their good
performance, the use of inteins in synthetic biology applications
still face challenges, hindering their widespread adoption by the
community. One major issue is the identification of intein inser-
tion or split sites. Whilst this shares some similarities with the
search of a general split site, the presence of an intein introduces an
extra layer of complexity—inteins require specific extein junction
sequences for efficient splicing19,20. The composition of amino acid
residues around a chosen split site needs to be carefully considered.
Alternatively, one can insert characterized extein junctions at a
putative split site, or modify host protein residues around a
putative split site to satisfy extein junction requirements. Doing so
can risk perturbations to the protein structure and function. By
either approach, making educated guesses and then testing split
sites on the scale of trial-and-error remains the popular route for
researchers, and hence the design space is often sparsely and
inefficiently sampled16,21,22.
Multiple solutions were proposed and reported in the literature
to tackle this problem. For instance, the SPLICEFINDER23,24
streamlined the molecular cloning processes to rapidly integrate
inteins at sites chosen by researchers, accelerating the build-test
cycles. Computation algorithms were also developed to predict
split sites from solved or modeled protein structures. One method
searches for flexible regions on protein structures and regions that
lack functional conservation, and was demonstrated on inserting
the gp41-1 intein on genes encoding antibiotic resistances17,18.
Another method abbreviated SPELL25 takes protein structures,
calculates split energies and identifies surface-exposed loops that
contains low conservation in sequences to predict split sites. Yet,
SPELL was designed to split proteins with a pair of chemically
inducible dimerization (CID) domains, and so might not be fully
compatible with intein insertions.
While these computational methods provide better rationality
in testing split sites, they rely on protein 3D structures. Thus, they
could suffer from reduced accuracies if structures were built by
modeling. This is suboptimal for synthetic biologists, who
often deploy novel and exotic proteins that typically receive
insufficient attention to warrant structural elucidations. In addi-
tion, testing only a few split sites risks missing the optimal sites,
and this could jeopardize the overall performance of larger syn-
thetic systems if they comprise split intein-inserted proteins as
key components.
Here, to facilitate split site identification for synthetic biology
applications, we customize and improve previously described
mini-Mu transposon-based approaches26–30. We develop a
bisection mapping method that involves the fusion of split inteins
to bisected host proteins. The technique is applied to five proteins
and reveals novel split sites for achieving the AND and NAND
logic. We highlight the advantage of using an intein compared to
interacting domains in splitting proteins, employ our method to
evaluate a single case of split site prediction from protein sec-
ondary structural homology, and describe suppressing uninduced
activities by splitting highly active proteins. Finally, we also make
an attempt to engineer switchable inteins, and demonstrate in
principle that a small of degree of post-translational inducibility is
introduced into an intein for drug-dependent control of protein
function.
Results
Designing the IBM workflow for split site screening. In pursuit
of a systematic protocol to search for split sites for inteins, we
drew heavily from library approaches, which are well-suited for
non-rational protein engineering. We utilized the mini-Mu
transposon, bisection mapping26 (BM) and domain-insertion
profiling27,28 (DIP), and incorporated features from the latter into
the former. In brief, the method (Fig. 1a and Supplementary
Fig. 1) starts with an in vitro transposition reaction that randomly
inserts a BbsI and SapI-flanked transposon into a staging vector,
which hosts a slightly trimmed, BsaI-flanked coding DNA
sequence (CDS) of interest (Supplementary Fig. 2). This is fol-
lowed by size selection of the insertion library such that only CDS
fragments with insertions will be isolated and ligated into a vector
for protein expression. A Golden Gate reaction was then used to
irreversibly substitute the transposon with a DNA fragment. The
fragment carries a selection marker, a split intein, and tran-
scription and translation initiation elements for carboxyl-lobe (C-
lobe) expression. In-frame insertions in the right orientation will
thus split a CDS into two with the amino-lobes (N-lobes) and C-
lobes of the split intein as fusion partners, under separate control
of two inducible promoters. The final library is then screened for
individual clones that display functional activities only when the
chemical inducers for both promoters are present. The clones are
then sequenced at the fusion joints to reveal the split sites.
For the split intein, we first selected the Ssp DnaBM86 intein31
(thereafter referred as the M86 intein) since it only requires the
−1 and +1 extein residues for splicing. These extein residues
are incorporated into the substitution insert. Successful splicing of
the M86 intein would leave behind a highly predictable four-
residue peptide linker at the split site of the original protein
(Supplementary Fig. 3). Our method emphasizes the use of an
intein in bisection mapping—hence the name intein-assisted
bisection mapping (IBM).
mCherry-M86 intein fusion for demonstrating the IBM
workflow. To preempt potential difficulties in troubleshooting if
the IBM workflow returned no functional split sites, we first
carried out a proof of principle test utilizing mCherry as the target
protein to be split. mCherry has been employed as a reporter for
Bimolecular Fluorescent Complementation (BiFC) and two split
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sites, 159/160 and 174/175, were known to create bipartite lobes
that would regain functionality if brought into proximity32. We
created a split mCherry construct that simulated the known split
site 159/160 being sampled by IBM. This construct only gave
increased fluorescence when the inputs for N-lobes (inducible by
arabinose) and C-lobes (inducible by AHL) were present (Sup-
plementary Fig. 4). Thus, provided enough library coverage, a
successful execution of the IBM workflow should generate the
simulated control as a member within the final library, and the
control should be recoverable afterwards.
Given the assurance, we proceeded to run the IBM workflow
on the mCherry protein (Fig. 1a). The resulting library was
induced with both arabinose and AHL. Cells with fluorescence
above autofluorescence were sorted by fluorescence-activated cell
sorting (FACS), plated and isolated as single colonies. Individual
strains were then assayed for responses in the absence or presence
of the two inducers, and those that showed AND logic behavior
were subsequently sequenced to identify the split sites. Pooling
the results yielded an intein-bisection map (Fig. 1b and
Supplementary Fig. 5). A total of 15 split sites were identified.
All split sites clustered into four seams, which were mostly located
on loops between the β sheets of the barrel. The second and the
third seams should cover sites 159/160 and 174/175, though
curiously, site 159/160 was not sampled by this IBM attempt. This
site was present in the library we screened (Supplementary
Table 1) and was left out fortuitously, likely due to under
sampling. Protein splicing took place at all split sites as evidenced
by a Western blot experiment on whole-cell lysates, and we
observed that all C-lobes were consumed (Supplementary Fig. 6).
This proved that our IBM workflow can locate intein insertion
sites that support efficient splicing.
To our knowledge, the seams 121/122 and 185/186–194/195
were never described to contain functional split sites before. Of
equal interest was the fact that four split sites, while close to the
loops, were found between amino acid residues that constituted
the β sheets (Fig. 1c), and this could suggest tolerance of either
structural disruption or inserted linkers, both of which are
unlikely to be ever tested if split sites were designed rationally.
Together, these two observations showcased that IBM has the
potential to discover novel and unexpected split sites.
We also noticed that sites within seam 185/186-194/195
yielded a low level of fluorescence when the cells were grown
under prolonged induction (24 h) of the N-lobe alone. Other
bipartite mCherry split at other seams did not show such
behavior. This might be explained by a leaky Plux2 promoter, and
the fact that mCherry split at the last seam would produce
relatively shorter C-lobes that were easier to transcribe and
translate.
Fig. 1 Proof-of-concept of Intein-assisted Bisection Mapping (IBM) on mCherry to recover known split sites for BiFC and discover new ones.
a Workflow. A transposon was randomly inserted into the mCherry CDS, and was then substituted with a DNA fragment containing the split intein Ssp
DnaBM86. This generated a library of mCherry-split intein fusions that can be screened for fluorescence only when both the N- and C-lobes were
expressed. AHL acyl homoserine lactone. b Two new loops for split sites were identified on mCherry and two existing ones were recovered. Each vertical
group of spots represents an identified split site, aligned to the mCherry secondary structure below. The majority of sites are between the β-sheets of the
barrel. y locations and error bars are mean and SD of median fluorescence from experiments performed on three different days (n≥ 3, see Supplementary
Data 2, sheet “sample_sizes” for exact values of n). Horizontal dashed lines bound the range of fluorescence that split mCherry could yield. See
Supplementary Fig. 5 for site distributions and activities at 5 h. c Split sites mapped to a reconstructed mCherry 3D structure (PDB: 2H5Q). Each split site
has the −1 and the +1 amino acid residues colored. d Representative split sites from each loop on mCherry permitted biomolecular fluorescence
complementation (BiFC). Single-cell fluorescence values were pooled from three biological replicates. Solid black horizontal lines denote population
median, except for autofluorescence which was denoted by dotted gray lines.
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Since the literature reported split sites on mCherry were
developed for bimolecular fluorescent complementation32, we
asked whether the new split sites identified could serve the same
purpose. We arbitrarily selected one or two representative split
sites from each seam. We also included three additional sites that
were found within the β-sheets. For each site, we built split
mCherry constructs where the split M86 intein was removed or
replaced by a pair of synthetic and heterodimerizing coil-coiled
domains, SYNZIP17 and SYNZIP1833 (Fig. 1d and Supplemen-
tary Fig. 7). For all constructs where split sites were on flexible
loops, increase in fluorescence could be observed when both lobes
were expressed with SYNZIPs, demonstrating that for mCherry,
tolerances of the IBM-identified split sites to protein fusion were
not unique to the intein. Sites within the β-sheets, except 176/177,
did not yield an increase in fluorescence, likely due to structural
disruptions to the β-barrel. To test whether the N-lobes and C-
lobes could complement without external help from SYNZIPs, we
removed SYNZIP17 from the N-lobes. Results showed no
increase in fluorescence and Western blots proved that it was
not due to the lack of protein expressions. Of note, two of the
tested split sites 191/192 and 192/193 produced overall stronger
BiFC activities while their C-lobes were more limited in
abundance. This further showed that the IBM pipeline can
identify the globally optimal sites to maximize performance of a
split protein for a defined application.
IBM with the gp41-1 intein identified a new split site on β-
lactamase. The IBM workflow is modular in design and switching
to another intein should be as simple as employing a new sub-
stitution DNA fragment during the step of transposon replace-
ment in Fig. 1a. To demonstrate this, we employed the gp41-1
intein34 with the −2, −1 and +1, +2 minimal extein residues
(GY/SS)35 and passed the TEM-1 β-lactamase (abbreviated as
BLA in figures) through the IBM pipeline. We chose this protein
for the same reason as mCherry, as it has a solved crystal
structure and a well-established split site at 194/19636 or 195/
19637. Furthermore, it has an additional split site 104/105 that
was computationally predicted and verified17.
In the screening process, we enriched ampicillin-resistant split
constructs through selection and outgrowth. Subsequent sequen-
cing on candidate clones revealed six split sites on two split seams
(Supplementary Fig. 8). The first seam, consisting sites 192/193
and 196/197 corresponded to the established site of 195/196.
Whereas the second seam (260/261, 261/262, 264/265, and 267/
268) represented a previously unreported split location. We did
not recover site 104/105, but this could be due to the clones being
outcompeted during the enrichment process. Regardless, our
results indicated that IBM works with two different inteins.
Applying IBM to engineer AND and NAND logic gates. Having
established the IBM workflow, we then sought to demonstrate its
universality in engineering protein-based logic gates38–40. We
focused on transcription factors because their responses could be
directly converted to an assayable fluorescent output (Fig. 2a). We
chose the repressor TetR and its homolog SrpR from the same
protein family41, and an activator, the extra cytoplasmic sigma
factor 20 (ECF20)42. Each protein was fed into the IBM workflow
using the M86 intein and a corresponding intein-bisection map
was generated. Three split seams and 32 split sites were found for
TetR; 4 seams and 13 sites for SrpR; 3 seams and 17 sites for
ECF20 (Fig. 2b–d and Supplementary Figs. 10–12). Most of the
split sites for TetR clustered around loop regions between helices
from the TetR crystal structure (PDB: 4AC0, Supplementary
Fig. 13). It is noteworthy that the same was observed for SrpR and
ECF20 even though their shown secondary structures were only
predictions that we generated from JPred443. The performance of
the logic gates in the aspect of on and off states strongly depended
on the split protein, the split site locations as well as the time
elapsed since induction. Across most split sites found in TetR and
ECF20, the split proteins would show qualitative NAND and
AND gate behavior with good repression and activation strengths
at both 5 and 24 h. For SrpR, most split sites yielded NAND gate
behavior at 5 h post-induction with observable levels of repres-
sion, but at 24 h, expression of C-lobes alone sufficed to evoke a
strong repression, rendering the circuit more like a single input
responsive gate (Supplementary Fig. 11). This was caused by the
accumulation of the N-lobes from leaky ParaBAD expressions over
time and the NAND behavior could be restored by eliminating
the leakiness (Supplementary Fig. 14), proving that neither the N-
lobe or the C-lobe alone was capable of repression. Our results
thus demonstrated that the IBM workflow is generally applicable,
works on proteins with no solved 3D structures, and exhausts
most possible sites. This allows researchers to choose the optimal
logic gates for their bespoke applications.
IBM indirectly defined functional boundaries on the ECF20
activator protein. While screening the colonies for AND gates in
ECF20, we observed that some yielded strong activation activities
from the expression of N-lobes alone, which emulated the
responses of an intact protein and addition of C-lobes did not
further improve activities. We thus surmised that they could be
truncations at the C-termini and sequenced some of them.
Indeed, those split sites were clustered at 178–185 (Fig. 2d) and
approximately corresponded to the end of the last helix on
ECF20, suggesting that the residues beyond position 178 could be
trimmed without a loss of function. In contrast, the first helix was
crucial since the first AND gate split site was found immediately
after the helix. These two observations suggested that IBM is not
only useful for synthetic biology, but has potential applications in
general biology, in determining the minimal functional size of a
protein.
Use of an intein expands the range of split sites discoverable in
TetR. Previously reported approaches in bisection mapping
for engineering logic gates utilized protein–protein interacting
domains like the SYNZIPs as fusion partners29. We hypothesized
that inteins make a better choice because they would be excised
from the splice product, whereas additional domains could exert
steric hindrance, especially when the host protein function
requires multimerization or interactions with other proteins. To
test our hypothesis, a representative site from each split seam
identified on the split TetR was selected and the split M86 intein
was replaced by SYNZIPs in a similar manner as above (Fig. 3a).
Of the three tested sites, site 166/167 showed a stronger level of
repression (~4-fold) compared to the other two (~2-fold), despite
having the least possible amount of reconstituted protein (Sup-
plementary Fig. 15). The differences in repression strengths
between split sites, when SYNZIPs were used, demonstrated their
differential tolerances towards additional domains. Whereas in
IBM, all three sites showed good levels of repressions that were
strong enough to be identified from a single screen. Hence, the
use of an intein could enable split sites that might be inaccessible
by protein–protein interacting domains, and expands the range of
split sites that can be identified for logic gate engineering.
IBM revealed limitations in inferring split sites from secondary
structure alignment. While IBM discovers split sites exhaus-
tively, it entails more preparation and work than simple guesses
and trial-and-errors. Ideally, if the intein-bisection maps on a
representative protein of a known family can inform split site
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selections on other proteins of the same family, then it might
obviate the need to perform IBM on every new protein. Since we
had split site data for both TetR and SrpR, both belonging to the
TetR family orthologs, we asked how reliable it was to infer split
sites assuming only one of the two proteins were bisection
mapped. To this end, we took a conventional approach and
aligned their sequences, their predicted secondary structures44,
and their split sites for the M86 intein (Fig. 3b and Supplemen-
tary Fig. 16). The alignment indicated that only two split seams
are shared between TetR and SrpR. Typically, loops that are
common to both structures would be assumed to contain putative
split sites45, but on the alignment, sites on seam 2 of TetR and
seam 3 of SrpR were mapped to a consensus helical region, and
they would be overlooked if split sites were cross-inferred. Like-
wise, on SrpR split sites were found on the loop that demarcates
the DNA binding domain from the dimerization domain, but
those sites would be unexpected if TetR served as the reference
model. Our results therefore suggest the secondary structure
alignment approach might sometimes work, but to ensure guar-
anteed discovery of insertion sites for split inteins, the IBM
approach should be undertaken and the effort would be well-
justified.
Mitigation of undesirable basal activities in highly active pro-
teins through IBM. Serendipitously, we discovered that split-
ting highly active proteins could suppress their background
activities. This has important implications for split intein
applications and protein function control. The observation was
best illustrated by the IBM generated split β-lactamases
(Fig. 3c). When the full CDS of β-lactamase was placed under
the control of ParaBAD, the hosting bacteria could grow in
ampicillin regardless of arabinose addition, proving that leaky
expression of β-lactamase was sufficient to confer resistance. In
contrast, split β-lactamases did not lead to cell growth if
inducers were absent. This tightening of protein expression
control could also be concluded from further analyses of single-
cell fluorescence data from Fig. 2. Intact TetR and SrpR had
stronger repression than their bipartite counterparts at 5 h. At
24 h, however, in the absence of induction the fluorescence of
unrepressed cells was much lower (Fig. 3c and Supplementary
Fig. 17). Whereas many bipartite repressors at 24 h had higher
unrepressed fluorescence, better separation of populations
between on and off states, and hence high fold changes. This
phenomenon was even more pronounced on the ECF20 acti-
vator—at 5 h, basal activities already gave a strong off-state
fluorescence and four split constructs started to benefit from
fold change improvement, and at 24 h the average fold change
of the worst performing split ECF20 construct was around 54
compared to 22 of the intact ECF20 (Supplementary Fig. 17).
These data from β-lactamase, repressors, and activators implied
that intact proteins had accumulated over time due to leaky
expression from a single promoter, but when they were split by
IBM and placed under independent promoters, the conferred
AND logic led to a lower probability of assembling a functional
protein, thereby reducing the overall undesirable basal activities
at the off states. Our result pointed to IBM as a potential
solution for tightening control over protein functions. This can
be valuable in regulating activities of cytotoxic peptides or
enzymes whose activities impose strong cellular burden.
Fig. 2 IBM as a universal method to exhaust split sites for AND and NAND logic gate engineering. a Any transcription factor with a function that can be
wired to an assay-friendly output could be subjected to IBM for logic gate engineering. b–d Intein-bisection maps for TetR (b, 3 seams identified), SrpR (c,
4 seams), and ECF20 (d, 3 seams). Split clones of TetR and SrpR (or ECF) achieved major off (or on) activities when both the N-lobes and the C-lobes were
present. y locations and error bars are mean and SD of median fluorescence from experiments performed on three different days (n≥ 3, see Supplementary
Data 2, sheet “sample_sizes” for exact values of n). Vertical dashed lines bound the permitted transposition window and horizontal dashed lines bound the
ranges of activities that could be attained by the split proteins. DMF dimethylformamide, DAPG 2,4-Diacetylphloroglucinol. d By-products of IBM revealed
a truncatable region of ECF20 which when removed did not adversely affect activation. b–d See Supplementary Fig. 10–12 for site distributions and
activities at 5 h (TetR and ECF20) and 24 h (SrpR). See Supplementary Fig. 9 for explanations of controls (leftmost subplots).
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A proof-of-concept attempt to engineer switchable inteins by
transposon-mediated domain-insertions. In theory, our IBM
workflow should allow one to use a conditional intein46–48 in
place of a split intein, and then screen for insertion or split sites
that would enable post-translational control of protein function.
We thus synthesized and tested three reported chemogenic con-
ditional inteins49–51 from the literature, but they did not work
well under our specific context in E. coli (Supplementary Fig. 18).
We asked instead whether we could create inducible inteins de
novo, by transposing drug-controlled domains into the
spontaneous splicing M86 intein (Fig. 4a). We tested two of these
domains: the ligand binding domain of human estrogen receptor
(ER-LBD)28, and the camelid anti-caffeine VHH (acVHH)
antibodies52,53.
Insertion of the ER-LBD domain was known to obstruct proper
protein folding until the binding of 4-hydroxytamoxifen (4-HT),
which then elicits a structural change and relieves the effect28. We
thus aimed to use this domain to control protein splicing. To do
so, we first positioned the contiguous M86 intein between
mCherry(1–192) and mCherry(193–236), given that this
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mCherry split site performed well in the fluorescence comple-
mentation experiment (Fig. 1d). Through our transposition
workflow, the ER-LBD was then randomly inserted, and possible
insertion sites were limited to the CDS of the contiguous M86
intein only (Fig. 4b and Supplementary Fig. 19). We induced
protein expression by the addition of arabinose, performed a
series of positive and negative cell sorting with or without 4-HT,
then characterized and sequenced candidate strains. Seven
insertion sites were identified, and small but distinguishable
differential responses between uninduced and induced states
could be observed at 24 h. We selected two constructs and
subjected them to a gradient of 4-HT induction, then inspected
their fluorescence and whole-cell lysates (Fig. 4c). As 4-HT
concentration increased, both showed a dose-dependent upshift
of fluorescence, and at site 85/86, a gradual increase of spliced
product formation could be observed on the Western blot.
However, most precursors did not undergo splicing and a low
level of splicing happened even when no 4-HT was added. All
seven ER-LBD inserted M86 inteins were inserted into site 101/
102 of ECF20 but failed to control the activity of the activator
(Supplementary Fig. 20).
In a separate attempt, we aimed to engineer chemically
inducible dimerization into the M86 intein. We chose to insert
the acVHH domains since, in the presence of caffeine, they could
homodimerize and reconstitute a split T7 RNA polymerase54
(Supplementary Fig. 21), and caffeine is inexpensive. We
transposed two acVHH domains, each with a 10-residue linker,
into the contiguous M86 intein. The intein was already inserted
between ECF20(1–101) and ECF20(102–193). The resulting
constructs were bipartite proteins, with each part driven by one
arabinose inducible promoter. After cell sorting and sequencing,
we obtained 12 split sites close to the M86 N-terminus. They had
increased fluorescence when cells were grown under 100 µM
caffeine for 24 h and being compared to the lack of caffeine
induction (Fig. 4d and Supplementary Fig. 22). All positions
showed either strong basal and strong maximum activities or
weak activities for both states. We characterized two sites, 17/18
and 39/40, for dose-dependent activation under different
arabinose concentrations (Fig. 4e and Supplementary Fig. 23).
Activation was an increasing function of caffeine and the
responses resembled a Hill curve. Reducing arabinose concentra-
tion reduced leaky activation at the expense of the overall
activities. This could be due to decreased spontaneous assembly
rates when intracellular protein concentrations were driven down.
We then cloned these two inteins, and an additional intein
bisected at 22/23, back into mCherry split at 192/193 to test if
they were transferrable, but there were no traces of splicing
(Supplementary Fig. 24). We speculated the splicing efficiencies
under caffeine induction were too low and only worked with
ECF20 given its extreme potency in activation.
Our efforts to create new switchable inteins through domain
transpositions have yet to produce practical tools for protein
function control. Nevertheless, we achieved a proof-of-concept
demonstration and produced prototypes where imperfect indu-
cibility could be engineered into inteins systematically.
Discussion
We have established IBM as a useful tool for split protein-intein
engineering. Thus far we have only employed the Ssp DnaBM86
and the gp41-1 intein. Repeating our IBM experiments using
different split inteins may reveal even more split sites at new
positions, since extein junctions with different amino acid com-
positions and lengths would be incorporated. This may alter the
rigidity of the resulting linkers and hence functionalize other
unprobed split sites. If shorter linkers are desired, a promiscuous
intein55 should be helpful, since a designated +2 extein residue
can be omitted and supplied by the host protein.
Our IBM workflow addresses issue of split site identification by
an empirical approach, and therefore does not face the same
constraints encounter by computational methods by Palanisamy
et al.17 and the SPELL algorithm25. For split site predictions,
sometimes solved 3D structures may be unavailable and de novo
structure prediction might not sufficiently reflect the multi-
merization required in some proteins like TetR. Conversely, IBM
requires the protein function to be manifested as an easily
screenable output and would be tremendous difficulty or outright
impossible if the function of interest is, for example, chemotaxis.
It also requires a chassis capable of creating a complex library
through highly efficient transformation, and so for the time being
it only applies to bacteria or yeasts. These limitations are absent
in the computational methods for split site predictions, however.
Furthermore, data from IBM may be fed back into and refine
those algorithms. We therefore advocate IBM/acVHH-assisted
BM not as a competitor, but rather, a complement to the com-
putational approaches.
In this work, we created two inducible variants of the M86
intein. At the current stage, these two inteins have limited
dynamic ranges and strong spontaneous splicing activities, and
thus are specific to their protein contexts where they were
screened. Therefore, our work is a proof of concept, and is only
the first step towards a systematic approach in converting
spontaneously splicing inteins into conditional ones. So far only
the M86 intein was tested as the engineering precursor. Other
inteins standardized by our group lately3 might lead to condi-
tional inteins with better on-off characteristics. There are also
other synthetic ligand binding domains, for example, uniRapR56
and iFKBP/FRB57 that are potential replacements for ER-LBD
and acVHH. Given so, the performance of any inducible intein
engineered through this method may depend on complex inter-
actions between the intein of choice, the drug-responsive domain,
the insertion/split positions and the host protein itself. Hence,
future efforts in engineering more inducible inteins would likely
require a combinatorial exploration of all four factors to identify
the optimal structure for drug-induced protein splicing, and our
Fig. 3 Benefits of IBM and reduction of basal activities by IBM. a Substitution of the split M86 intein inserted in split TetR by SYNZIP. Representative
sites were chosen within the three identified split seams. Results showed different split sites had differential tolerances towards additional protein domains,
but all split sites functioned well when the intein was used (Fig. 2b). Single-cell fluorescence values were pooled from three biological replicates (n= 3).
b IBM-identified split sites of homologous TetR and SrpR do not necessarily map to loops between consensus helical domains, highlighting the limitation of
guessing split sites for a new protein by secondary structure alignment. HTH helix-turn-helix. c Splitting highly active proteins can reduce their basal
activities. Left panel: leaky expressions of β-lactamase (BLA) led to ampicillin resistance in the absence of induction, which could be improved by splitting
BLA. Middle and right panels: fluorescence distributions and fold changes between fully on and fully off states of intact and split TetR and ECF20 were
shown. Representative sites were chosen from each identified seam. In most cases the split clones had lower basal activities and therefore larger fold
changes between on and off states. Single-cell fluorescence values were pooled from experiments performed on three different days (n≥ 3, see
Supplementary Data 2, sheet “sample_sizes” for exact values of n). DAPG 2,4-Diacetylphloroglucinol. b, c Data reused from Fig. 2 and Supplementary Fig. 8
but further analyzed. a, c In fold change calculations, bar heights and error bars represent mean and SD.
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Fig. 4 Transposon as a tool to engineer inducibility into an intein for protein function control. a The M86 intein in its cis-form can be inserted in an
identified split site within the protein of interest, and then bisected or inserted with drug-controlled domains, which leads to inducible splicing and inducible
function of the host protein. b Seven insertion sites identified via domain-insertion mapping of the estrogen receptor-ligand binding domain into the M86
intein within mCherry interrupted at 192/193, where the addition of 4-hydroxytamoxifen (4-HT) led to increased fluorescence. c Selected clones from
b showed gradual increase in fluorescence and spliced product formation as the concentrations of 4-HT increased, despite the fact that most precursors
were unspliced. Single-cell fluorescence values were obtained from one biological sample. Interquartile ranges are denoted by horizontal dashed lines.
mCherry N-lobes were labeled in red and C-lobes were labeled in turquoise, and their superpositions give a white color. The result is representative of two
independent experiments with similar results. d Eleven split sites for anti-caffeine VHH identified on the M86 intein that interrupted the activator ECF20 at
101/102. In those clones, the addition of caffeine led to increased activation activities. e Selected clones from d had increased activation activities as
caffeine concentration increased, and leakiness due to spontaneous assembly could be mitigated by lowering the total split protein concentrations. y
locations and error bars are mean and SD of median fluorescence of three biological replicates each assayed on a different day (n= 3). b, d Each vertical
group of spots represents an identified insertion/split site, aligned to the M86 intein secondary structure. See Supplementary Figs. 19, and 22 for site
distributions and activities at 5 h. y locations and error bars are mean and SD of median fluorescence from experiments performed on 3 different days (n≥
3, see Supplementary Data 2, sheet “sample_sizes” for exact values of n). DMSO dimethyl sulfoxide. b, d, e Horizontal dashed lines bound the maximum
(b and d only) and minimum fluorescence that could be achieved by the split or inserted constructs.
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transposition method should be useful since the components are
modular—the same library of an intein being bisected can be
cloned into different host proteins, and the transposon can also
be swapped out by different substituting domains.
The limited performance of the two inducible inteins from this
study could also be improved via directed evolution21,31,49,58,59,
which can mutate these inteins such they splice with better effi-
ciencies and with lower basal activities, and allow them to per-
form sufficiently well when inserted into other host proteins. We
foresee a powerful combination between domain-insertion/
acVHH-assisted bisection mapping and directed evolution, where
the former identifies the optimal sites for differential activities.
The sites can then be exploited by the latter which can use the
differential responses to prime the evolution process. This should
create more inducible inteins which would be valuable tools when
additional domains on a protein cannot be tolerated (Supple-
mentary Fig. 25).
Our IBM workflow employs random transposition to diversify
DNA insertion. This method has known issues including
sequence bias60–64 and inexhaustive space search27,28,64,65.
Despite so, in our final libraries prior to screening, sequenced by
Next Generation Sequencing (NGS), we obtained at least 87%
coverage on possible amino acid split/insertion positions (Sup-
plementary Fig. 26 and Supplementary Table 1), which suffi-
ciently explored the sequence space. If unbiased and full position
coverage is desired, the step of random transposition should be
replaced by the recently developed Saturated Programmable
Insertion Engineering (SPINE)64, which hardcodes all insertion
possibilities into oligonucleotide pools. Incorporation of SPINE
into the IBM workflow should return bisection/insertion maps
with higher confidences.
In summary, we presented a robust method to screen and
identify protein split sites for the insertion of a split intein. We
have recently characterized a library of orthogonal split inteins3.
With the help of IBM, a large number of orthogonal AND or
NAND gates can be created in a streamlined fashion, expediting
the development of biocomputing units. Moreover, we demon-
strated in principle that transposing drug-controlled domains
could create prototype switchable inteins, and that they, to some
extent, controlled host protein functions post-translationally.
Together, they constitute an empirical and systematic approach
towards split protein and protein function control engineering,
and should benefit general biologists who seek to use inteins on
split proteins.
Methods
Strains, media, and inducers. Escherichia coli TOP10 (Invitrogen) was used for
routine cloning. For all bisection/insertion mapping, the first insertion libraries
were always transformed into the electrocompetent E. coli NEB 10-beta
(C3020K, NEB). For the rest of the workflow the strain was switched back to
TOP10. The only exception was the IBM experiment on mCherry and its out-
come simulation experiment, where NEB 10-beta was used in all steps. All
strains were grown in the Miller’s Lysogeny Broth (LB, 10 g L−1 tryptone, 5 g L−1
yeast extract, and 10 g L−1 sodium chloride) in liquid medium or agar supple-
mented with the appropriate antibiotics (unless noted otherwise) at the final
concentrations of: kanamycin (K4000, Sigma-Aldrich), 50 µg mL−1; chlor-
amphenicol (C0378, Sigma-Aldrich), 25 µg mL−1; ampicillin (A9518, Sigma-
Aldrich), 100 µg mL−1; tetracycline (T8032, Sigma-Aldrich), 10 µg mL−1, spec-
tinomycin (ab141968, Abcam), 50 µg mL−1.
For preparation of stock inducers, powder of L-(+)-Arabinose (A3256, Sigma-
Aldrich, 1M), N-(3-Oxohexanoyl)-L-homoserine lactone (AHL, K3007, Sigma-
Aldrich, 25 mM), or caffeine (A10431.22, VWR, 10 mM) was dissolved in water;
2,4-Diacetylphloroglucinol (DAPG, 16345, Cambridge BioScience, 25 mM), in
dimethylformamide (D4551, Sigma-Aldrich); Rapamycin (S1039-SEL, Stratech,
10 mM), (Z)−4-hydroxytamoxifen (4-HT, H7904, Sigma-Aldrich, 10 mM), 3,3′,5-
triiodo-L-thyronine (T3, HY-A0070A, Cambridge BioScience, 10 mM) in dimethyl
sulfoxide (D8418, Sigma-Aldrich), with the stock concentrations denoted in
brackets. For inductions involving inducers dissolved in organic solvents, the
volumes of inducer were less than or equal to 1% of the final volume.
Molecular cloning. Synthetic DNA constructs were built using Gibson
Assembly66, Golden Gate Assembly67 and conventional subcloning using restric-
tion digestion and ligation, with the method chosen depending on their individual
needs. Whenever necessary, synonymous mutations were introduced to remove
internal BsaI, BbsI, or SapI restriction sites. Standard molecular biology protocols
were observed. The ZymoPURE II Plasmid Midiprep Kit (D4200, Zymo) was used
for DNA library extractions. For the purification of DNA, the Monarch Nucleic
Acid Purification Kits (T1020 and T1030, NEB) were used. All restriction enzymes
and ligases were bought from NEB. MuA protein was purified in collaboration with
Domus Biotechnologies (Turku, Finland)68. List of constructs and list of oligo-
nucleotides used in this study are detailed in Supplementary Data 1.
Cell growth for fluorescence assays and OD measurements. Cells were routi-
nely cultured in 96-well plates (655096, Greiner Bio-One) sealed with breathable
membranes (Z380059, Sigma-Aldrich), and incubated at 37 °C in plate shakers
(AS-03020-00, Allsheng) with 1000 rpm orbital shaking motion. An assay of
synthetic constructs began with an inoculation of a single colony from an agar plate
into a well with 200 µL of medium, which was then grown for 16–18 h. The next
day, 2 µL of the overnight culture was diluted 1:100 into 198 µL of fresh medium
with or without inducers and grown for 5 h. The membrane was then removed and
2 µL of the culture was sampled. A new seal was applied, and the plate was returned
to the shaker to further grow until the total time of incubation was 24 h. After-
wards, 0.5 µL (24 h) of the culture were sampled. Changes to growth time were
noted in individual figures where appropriate. Exception to the above applies to the
split mCherry splicing experiment, the mCherry BiFC experiment and the split
TetR-SYNZIP experiment, where overnight cultures were diluted 1:100 into 1 mL
of fresh medium in 96-deepwell plates (E2896-2110, Starlab). For the assays of
strains identified from bisection/insertion mapping experiments, the overnight
culture was inoculated from the saved glycerol stocks (described below). Assays
measuring resistance against ampicllin were performed in a similar manner, the
only difference was that ampicillin was added at the same time as inducers, and
growth was only measured after 24 h.
Optical density measurements by plate reader. End-point optical densities at
600 nm (OD600) were measured with a FLUOstar Omega plate reader (BMG
Labtech). The software Omega Control v5.11 (BMG Labtech) was used for data
acquisition and Omega MARS v3.32 (BMG Labtech) was used for data export. The
optical densities of blank wells from the same plate were subtracted from all
other wells.
Fluorescence measurements by flow cytometry. Prior to analysis, sampled
cultures were diluted into 1× phosphate-buffered saline (K813-500ML, VWR) with
2 mgmL−1 kanamycin to a total volume of 200 µL. Diluted cells sampled at 5 h
were incubated at 4 °C for a minimum of one hour to promote fluorophore
maturation, whereas those at 24 h were directly assayed. Cells were passed into the
Attune NxT Flow Cytometer (Thermo Fisher) equipped with the Autosampler for
analysis. For each well, 100 µL of diluted cells were run at 500 µLmin−1 and at least
105 events were recorded. Red fluorescence was acquired on the YL2-H channel
(excitation 561 nm, emission 615/25 nm). Exported FCS files were processed using
an in-house Python script dependent on the FlowCytometryTools package v0.5.0.
All samples were gated on FCS-H and SSC-H for events between 103–105 arbitrary
units, followed by gating on YL2-A and YL2-H between 1 to 106 arbitrary units
(Supplementary Fig. 28a). For visualization, the FlowCal package v1.3.069 was used.
Transposition and bisection/insertion library preparations. A detailed protocol
for carrying out IBM is available at protocols.io70. The mini-Mu transposon used in
this study was modified from the one used by Segall-Shaprio et al.26 with BbsI and
SapI sites incorporated into the R1 recognition sites. Prior to transposition the
transposon was released from its host vector by restriction digestion using BglII
followed by purification from agarose gels. The coding DNA sequence of interest
was trimmed at the N-termini and C-termini before being subcloned into a staging
vector. In vitro transposition reactions were set up following an established
protocol71 with slight customizations: 150 ng of the staging plasmid and 150 ng
transposon were mixed with 660 ng of MuA. For each insertion library 5–6 reac-
tions of 25 μL each were prepared and incubated at 30 °C in a thermocycler for 6 h,
followed by heat inactivation at 80 °C for 10 min. All reactions were pooled, pur-
ified, and then eluted in 10 μL of nuclease-free water. The resulting DNA was then
electroporated into a total of 200 µL of NEB 10-beta cells in four separate cuvettes
and recovered following manufacturer’s protocol. Then, 10 µL of the recovered cells
(~2 mL) were removed, serially diluted into 0.85% sodium chloride (w/v) and
spread onto LB agar with kanamycin and chloramphenicol for colony counting.
The library coverage was defined as the total number of obtainable transformants /
(size of staging plasmid in bp × 2) and were at least 20-fold for all experiments.
Libraries that did not meet the coverage criterion were discarded and transposition
reactions were repeated. For libraries with sufficient coverages, the rest of the
recovered cells were spread onto LB agar. Bacterial lawns were then washed down
by 0.85% sodium chloride and a small aliquot was saved as a glycerol stock. The
rest were pelleted, and the DNA was extracted by midiprep.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-22404-9 ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:2200 | https://doi.org/10.1038/s41467-021-22404-9 | www.nature.com/naturecommunications 9
Ten microgram of the midiprepped DNA from the initial insertion library was
digested by BsaI and then resolved on agarose gels until bands were well-separated.
The bands corresponding to the trimmed coding DNA sequences with insertions
were then excised, purified, and ligated to the linearized expression vector in 1:2
molar ratio for insert:vector. The overnight ligated product was then purified and
electroporated into 100 µL of in-house-prepared electrocompetent cells, which
were recovered in 2 mL SOC for 1 h, concentrated and then spread onto LB agar
and grown overnight. Library coverage estimation and DNA extraction of the
library were performed similar to that in transposition, except that the size of the
insertable positions equals to the size of trimmed coding DNA sequence in bp. At
this stage library coverages were typically >500-fold.
To replace the inserted transposon with split inteins or drug-controlled
domains, 60 ng of the midiprepped DNA from the open reading frame (ORF)
insertion library was mixed with substitution inserts (released from the cloning
plasmids) in a 1:5 molar ratio for plasmid:insert, and added to a Golden Gate
reaction mixture67 with 20 units of BbsI, 10 units of SapI and 400 units of T4 DNA
ligase. The reaction was then run in a thermocycler with the following program:
(37 °C for 3 min, 16 °C for 4 min) × 25 cycles, 37 °C for 30 min, and 65 °C for
20 min. Usually 5–6 reactions were run, pooled, purified and electroporated into
100 µL of in-house-prepared electrocompetent cells. Electrocompetent cells carried
a reporter plasmid wherever required. Cells were recovered and the library
coverage estimation was performed in the same manner as the preparation of the
ORF insertion library. At this stage library coverages were typically >100-fold.
Library screening. For IBM on mCherry, recovered cells from the final library
were first induced with both arabinose and AHL, and sorted by fluorescence
activated cell sorting (see below). Retrieved cells were then spread onto LB agar for
colony picking. For IBM on β-lactamase, recovered cells from the final library were
first induced with arabinose and DAPG overnight, the culture was then diluted
1:100 in fresh medium containing arabinose, DAPG and ampicillin, and was grown
for another overnight. The resulting culture was serially diluted onto solid medium
with inducers and ampicillin for isolating single colonies. For IBM on TetR, SrpR,
and ECF20, recovered cells from the final library were serially diluted such that
single colonies could be observed when they were spread onto LB agar with ara-
binose and DAPG. For TetR and SrpR, functional reconstitution of the bipartite
protein represses expression of mScarlet-I and therefore yielded visibly white or
pale pink colonies. The opposite was true for ECF20. These colonies were picked
directly. For the M86 intein inserted with ER-LBD or the M86 intein bisected by
acVHH, recovered cells from the final library were first induced with arabinose and
4-HT or caffeine. They were then sorted for populations with fluorescence higher
than the library without 4-HT or caffeine induction (positive sort). Sorted cells
were regrown in the presence of arabinose only and then sorted for populations
with lower fluorescence (negative sort). The positive sort was repeated once, and
the retrieved cells were spread onto LB agar to obtain single colonies for picking.
Fluorescence activated cell sorting (FACS) experiment. For the initial sort, 100
μL of the library was inoculated into 25 mL of medium with inducers and grown
overnight for 18–24 h. The next day, 10 μL of the culture was diluted into 10 mL 1×
phosphate-buffered saline and then passed into the cytometer. Cell sorting was
performed on a FACS Aria IIu cytometer (BD-Biosciences) with BD FACS Diva
Software v6.1.3, through the red fluorescence channel (excitation 561 nm, emission
610/20 nm), under the Purity Mode. Cells were first gated on irregularly shaped
FSC-A and SSC-A gates to exclude non-cellular materials, and then gated on
boundaries defined by the previous libraries with or without induction. Gate sizes
and positions were tailored to individual experiments. See Supplementary Fig. 28b
for example gating strategies. Typically, 0.5–1 million gated events were collected
into a 15 mL conical tube with 5 mL of LB supplemented with 1 % D-Glucose
(10117, VWR) and without antibiotics. Collected cells were recovered for 2 h at
37 °C with 160 rpm shaking. Then, the volume was topped to 15 mL using LB with
the next set of inducers and grown overnight for 16–18 h for the next sorting
experiment. After the final cell sorting, the overnight culture was diluted and plated
onto LB agar to obtain single colonies for strain isolation.
Candidate strain isolation, characterization, and split/insertion site mapping.
In most cases >500 single colonies with desirable traits were individually picked
into 96-well plates with 200 µL of LB medium for 16–18 h of growth, which were
subjected to 16-24 h of induction assays to look for AND logic (mCherry, β-
lactamase and ECF20), NAND logic (TetR and SrpR), or differential expression
(with the M86 intein inserted or bisected). The fluorescence of the candidate clones
was then measured on the FLUOstar Omega plate reader (BMG Labtech) and
ranked. The best clones with desirable traits (~96 for IBM and ~40 for M86 intein
engineering) were isolated with assistance from an OT-2 robot (Opentrons). The
shortlisted clones were saved as temporary glycerol stocks and then subjected to
fluorescence assays as described above for proper characterization, which generated
the data for plotting the bisection/insertion maps. Strains that showed strong
experiment-to-experiment variations in fluorescence were excluded for further use.
A small aliquot of each cell strain in liquid suspension was then subjected to
polymerase chain reactions (PCR), which amplified the N-terminal (mCherry) or
the C-terminal (all others) joints. The PCR products were purified and sent for
Sanger sequencing. Poor sequencing results or reads that suggested non-single
clones were discarded. The rest of the sequencing results were analyzed with a
customized Python script utilizing the Biopython package v1.7672 to deduce split
or insertion sites by local alignment of sequences. Sites were mapped back to their
fluorescence profiles and protein secondary structures (rendered using the Biotite
package v0.20.173).
SDS-PAGE and Western blots for whole-cell lysate analysis. Cells cultured for
western blots were grown in 30mL universal tubes (E1412-3011, Starlab) placed inside
a shaker (Infors HT) maintained at 37 °C, 160 rpm. For each sample, a single colony
was inoculated into 2mL of medium and grown for 16–18 h. The next day, the
overnight culture was diluted 1:100 into 2mL of fresh medium with the appropriate
inducers and grown for 24 h unless specified otherwise. Then, where appropriate, 0.5
µL of culture was removed for fluorescence measure for flow cytometry, with the pre-
lysis fluorescent distributions displayed in the same figure. For detection of protein
expression, in most cases 1mL of culture was harvested. Exception to the above applies
to the split mCherry-split M86 intein splicing experiment, the mCherry BiFC
experiment and the split TetR-SYNZIP experiment, where the volumes of bacterial
culture harvested were adjusted by optical densities to standardize the amount of
cellular materials used in cell lysis. Bacterial cells were centrifugation at 17,000 × g and
resuspended in 50 μL of 1× Laemmli sample buffer (1610747, Bio-Rad), boiled at
100 °C for 10min, and centrifuged at 17,000 × g for 10min. Five or ten microliter of
the supernatant were resolved on an Any kD TGX Stain-Free protein gel (4568126,
Bio-Rad) alongside a Chameleon Duo Pre-Stained Protein Ladder (928-60000, Li-cor).
Protein contents were then transferred to a nitrocellulose membrane (1704270, Bio-
Rad) through a semi-dry transfer protocol (1704150, Bio-Rad). The manufacturer’s
protocol (Doc. #988-13627, Licor) was followed for blocking, antibody incubation,
washing, and detection of near-infrared probes on secondary antibody. We used 5%
(w/v) skimmed milk in 1× tris-buffered saline (1706435, Bio-Rad) as the blocking
reagent. The mCherry constructs involved in the western blot assays carried a hex-
ahistidine tag at the C-termini and an epitope (residues 27–41) exists within the N-
lobes. Bipartite proteins were detected using the rabbit anti-mCherry (A00682, Gen-
Script, 1:3000 diluted), the mouse anti-His (A00186, GenScript, 1:5000 diluted), and
the rabbit anti-HA (902303, Biolegend, 1:1000 diluted) antibodies. They reacted
against the IRDye 680RD goat anti-rabbit (925-68071, Licor) or the IRDye 800CW
goat anti-mouse (925-32210, Licor) secondary antibodies, both diluted at 1:20,000.
Membrane imaging was performed on the Odyssey CLx Infrared Imaging System
(Licor) and the resulting images were processed using Image Studio Lite
v5.2.5 software (Licor) and ImageJ74.
Secondary structure alignments by amino acids and protein 3D structures.
Secondary structures of SrpR and ECF20 were predicted using the JPred4 Server43,
or modeled via SWISS-MODEL75. SrpR and TetR amino acid sequences were
aligned with the known TetR structure (PDB: 4AC0) using PROMALS3D44 with
default parameters. 3D structures were rendered using the software PyMOL
v1.7.6.7 (Schrodinger).
Library preparation, next generation sequencing and data analysis. Glycerol
stocks of the final library were thawed and for each library, 200 μL of the stock was
inoculated into 50 mL of fresh medium for overnight growth. Subsequently the
plasmid DNA libraries were extracted by midiprep. For IBM libraries of mCherry,
TetR, SrpR, and ECF20, appropriate combinations of restriction enzymes were
used to release a minimal length of DNA fragments that contain mixed insertions
at various positions. Digested DNA were resolved on agarose gels and the frag-
ments with mixed insertions, which migrated as a single band, was excised and
purified. For the domain-insertion library of ER-LBD into the M86 intein which
was within mCherry, the region with insertions were amplified by PCR, then
resolved and purified from agarose gels. Purified DNA were sent to Novogene (UK)
for fragmentation and sequencing to obtain at least 7 million reads of 150 bp
paired-end per library.
The resulting data was processed by in-house developed Python scripts. 12 bp,
each at the 5′ and 3′ termini of the final inserted DNA were defined as signature
sequences. Raw FASTQ files were filtered for reads that contained perfect matches
to these signature sequences. Then, for each filtered read, the signature sequences
were aligned and the adjacent sequence (12 bp) was extracted from the read, which
were then aligned back to the CDS of the target protein to determine insertion
positions. Only unique and perfect matches were considered authentic and a split/
insertion site was called. Any fragments, where the forward and reverse reads
reported different split/insertion sites were removed, and fragments where the
forward and reverse reads pointed to the same split/insertion site were
deduplicated to avoid double counting. Rare instances of sites mapped beyond the
permitted transposition window were also removed. Similar to previous works, a
productive split or insertion site on the amino acid sequence was called only if the
insertion orientation was forward and the insert was in-frame.
Data processing and statistics. All data were processed and graphed in Python.
Whenever displayed, fluorescence distributions shown within the same subpanel
were normalized to their individual modes. We used two-tailed t-tests for inde-
pendent samples assuming unequal variances in comparisons of fold changes
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between median fluorescent values, and in comparisons of median fluorescent
values from populations. Calculations were done in Python using the SciPy package
v1.4.176. Exact sample sizes (n) were described in figure legends, but in cases where
sample sizes (n ≥ 3) of different sites differed greatly between groups and were too
numerous to report as exact values, we refer to Supplementary Data 2, sheet
“sample_sizes” for exact values. Owing to the large number of statistical tests
performed within a single figure panel, we did not report the individual statistics
and p-values but rather the summary statistics: n.s. not significant; *p ≤ 0.05; **p ≤
0.01; ***p ≤ 0.001. The exact p-values can be found in Supplementary Data 2,
under sheet “p-values”.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Source data, including uncropped western blot images and Python scripts for generating
figures, are deposited to the Edinburgh DataShare [https://doi.org/10.7488/ds/3001].
Uncropped western blot images are also present in a Source Data file. Raw sequencing
data of IBM and DIM final libraries from NGS are deposited to the Sequence Read
Archive under the project accession code PRJNA678813. List of constructs used in this
study are detailed in Supplementary Data 1, and their sequences are available on
SynBioHub77 [https://synbiohub.org/public/Intein_assisted_Bisection_Mapping/
Intein_assisted_Bisection_Mapping_collection/1]. Representative key constructs used in
this study, which allow researchers to conduct IBM of their own, are deposited at
Addgene (ID 161937–161955, see Supplementary Data 1 for details). Protein structures
for analysis, including mCherry (2H5Q) [https://www.rcsb.org/structure/2H5Q], TEM-1
β-lactamase (1ZG4) [https://www.rcsb.org/structure/1ZG4], TetR (4AC0) [https://www.
rcsb.org/structure/4AC0], and Ssp DnaBM86 intein (6FRH) [https://www.rcsb.org/
structure/6FRH] were assessed from the Protein Data Bank[rcsb.org]78,79. Source data
are provided with this paper.
Code availability
Python scripts for analyzing Sanger sequencing results to determine split sites at the final
step of IBM, and for analyzing split or insertion site coverages from NGS data, are
available at GitHub at https://github.com/tyhho/IBM80.
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